Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A pragmatic tool for drug discovery.

Journal article

Bobbitt DR. et al, (2020), Drug Discov Today

CV Care: Lipid-modifying Agents--From Statins to PCSK9 inhibitors

Journal article

PREISS D. and REITH C., (2019), JACC - Journal of the American College of Cardiology

Cost-effectiveness of lipid lowering with statins and ezetimibe in chronic kidney disease.

Journal article

Schlackow I. et al, (2019), Kidney Int, 96, 170 - 179

Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials.

Journal article

Cholesterol Treatment Trialists' Collaboration None., (2019), Lancet, 393, 407 - 415

ASSESSING BASELINE MEDICATION USE IN CHRONIC KIDNEY DISEASE: AN ANALYSIS OF THE SHARP-ER STUDY

Conference paper

Jun M. et al, (2018), NEPHROLOGY, 23, 25 - 25

Impact of CKD on Household Income.

Journal article

Morton RL. et al, (2018), Kidney Int Rep, 3, 610 - 618

Lowering LDL cholesterol reduces cardiovascular risk independently of presence of inflammation.

Journal article

Storey BC. et al, (2018), Kidney Int, 93, 1000 - 1007

A policy model of cardiovascular disease in moderate-to-advanced chronic kidney disease.

Journal article

Schlackow I. et al, (2017), Heart, 103, 1880 - 1890

Interpretation of the evidence for the efficacy and safety of statin therapy.

Journal article

Collins R. et al, (2016), Lancet, 388, 2532 - 2561

Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials.

Journal article

Cholesterol Treatment Trialists' (CTT) Collaboration None. et al, (2016), Lancet Diabetes Endocrinol, 4, 829 - 839

Smoking and Adverse Outcomes in Patients With CKD: The Study of Heart and Renal Protection (SHARP).

Journal article

Staplin N. et al, (2016), Am J Kidney Dis, 68, 371 - 380

Load More